A novel alpha- (N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production

Details for Australian Patent Application No. 2008319122 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Olson, Richard E.; Gillman, Kevin W.; Starret Jr., John E.

Agent A J Park

Pub. Number AU-A-2008319122

PCT Pub. Number WO2009/058552

Priority 60/984,118 31.10.07 US

Filing date 14 October 2008

Wipo publication date 7 May 2009

International Classifications

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058552 Priority application(s): WO2009/058552

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319124-Method and apparatus for peer to peer link establishment over a network

2008319111-Method and system for providing a seamless handoff between communication networks